137 related articles for article (PubMed ID: 1727122)
1. Fractionation is important for HDR cervix cancer brachytherapy.
Orton CG
Int J Radiat Oncol Biol Phys; 1992; 22(1):222-3. PubMed ID: 1727122
[No Abstract] [Full Text] [Related]
2. 5-year results with HDR afterloading in cervix cancer: dependence on fractionation and dose.
Vahrson H; Römer G
Sonderb Strahlenther Onkol; 1988; 82():139-46. PubMed ID: 3393979
[No Abstract] [Full Text] [Related]
3. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
[TBL] [Abstract][Full Text] [Related]
4. Clinical investigations and fractionation schemes in the treatment of cervix carcinoma with HDR afterloading at the Centre of Oncology in Gliwice.
Rattka P
Sonderb Strahlenther Onkol; 1988; 82():173-6. PubMed ID: 3393982
[No Abstract] [Full Text] [Related]
5. HDR brachytherapy for carcinoma of the cervix: fractionation considerations.
Brenner DJ; Hall EJ
Int J Radiat Oncol Biol Phys; 1992; 22(1):221-2. PubMed ID: 1727121
[No Abstract] [Full Text] [Related]
6. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
Kim WC; Kim GE; Suh CO; Loh JJ
Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
[TBL] [Abstract][Full Text] [Related]
7. Is HDR brachytherapy for carcinoma of the uterine cervix high-throughput but high risk?
Fowler JF
Acta Oncol; 1998; 37(2):113-5. PubMed ID: 9636004
[No Abstract] [Full Text] [Related]
8. Influence of HDR fractions and dose on the 5-year results and complications of cervix cancer.
Joslin CA; Kilara G; Khoury G
Sonderb Strahlenther Onkol; 1988; 82():100-5. PubMed ID: 3134703
[No Abstract] [Full Text] [Related]
9. Case report: low dose rate and high dose rate intracavitary brachytherapy in a patient with carcinoma of the cervix.
Tan LT; Jones B; Freestone G; Dale RG
Br J Radiol; 1996 Jan; 69(817):84-6. PubMed ID: 8785631
[TBL] [Abstract][Full Text] [Related]
10. Five-year results and complications with HDR afterloading in cervix cancer using a linear arrangement of source.
Mizoe J; Tsujii H; Kamada T; Arimoto T; Matsuoka Y; Shirato H; Tsuji H; Irie G
Sonderb Strahlenther Onkol; 1988; 82():114-8. PubMed ID: 3134705
[No Abstract] [Full Text] [Related]
11. Use of a plate applicator in the HDR radiation of cervix cancer: 5-year results and complications.
Alth G; Koren H
Sonderb Strahlenther Onkol; 1988; 82():166-72. PubMed ID: 3134714
[No Abstract] [Full Text] [Related]
12. The trail of the development of high-dose-rate brachytherapy for cervical cancer in Japan.
Inoue T
Jpn J Clin Oncol; 2003 Jul; 33(7):327-30. PubMed ID: 12949057
[TBL] [Abstract][Full Text] [Related]
13. Comparison of HDR afterloading with 192Ir versus conventional radium therapy in cervix cancer: 5-year results and complications.
Glaser FH
Sonderb Strahlenther Onkol; 1988; 82():106-13. PubMed ID: 3134704
[No Abstract] [Full Text] [Related]
14. Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer.
Stewart AJ; Viswanathan AN
Cancer; 2006 Sep; 107(5):908-15. PubMed ID: 16874815
[TBL] [Abstract][Full Text] [Related]
15. Analysis of late effects after HDR afterloading therapy of cervix carcinoma with the GammaMed II.
Alberti W; Busch M
Sonderb Strahlenther Onkol; 1988; 82():151-5. PubMed ID: 3393981
[No Abstract] [Full Text] [Related]
16. Optimization of high-dose-rate intracavitary brachytherapy schedule in the treatment of carcinoma of the cervix.
Patel FD; Kumar P; Karunanidhi G; Sharma SC; Kapoor R
Brachytherapy; 2011; 10(2):147-53. PubMed ID: 20685179
[TBL] [Abstract][Full Text] [Related]
17. Fractionated high-dose-rate brachytherapy in the management of uterine cervical cancer.
Park HC; Suh CO; Kim GE
Yonsei Med J; 2002 Dec; 43(6):737-48. PubMed ID: 12497657
[TBL] [Abstract][Full Text] [Related]
18. Dose rate definition with microSelectron-HDR and Selectron-MDR in brachytherapy for carcinoma of the cervix.
el-Baradie MM; Fournier-Bidoz N; Inoue T; Inoue T; Yamazaki H
Anticancer Res; 1998; 18(3B):2069-76. PubMed ID: 9677469
[TBL] [Abstract][Full Text] [Related]
19. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
Petereit DG; Sarkaria JN; Potter DM; Schink JC
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
